Skip to main content
Equibles

LINCOLN · Lincoln Pharmaceuticals Limited · Financials

Use LINCOLN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LINCOLN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
522.00 INR +3.60 (+0.69%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 1882 Avg daily vol (3M) 3104

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
6.71B +7.7%
FY2026 Revenue FY2018–FY2026
Net Income
0
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
1.06B +14.3%
FY2026 Operating Cash Flow FY2023–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2018
INR 7.22B 6.71B 6.23B 5.81B 5.1B 3.62B
INR 151.72M 145M 128.99M 106.25M 91.66M 61.12M
INR 11.49M 10.13M 18.83M 14.65M 20.3M 54.11M
INR 1.28B 1.16B 1.09B 1.22B 1B 462.47M
INR 311.02M 277.31M 268.42M 289.38M 275.81M 115.98M
INR 0 0 0 0 0 346.23M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 132.2M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.